Concurrent treatment of aplastic anemia/Paroxysmal Nocturnal Hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Concurrent treatment of aplastic anemia/Paroxysmal Nocturnal Hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience

Concurrent treatment of aplastic anemia/Paroxysmal Nocturnal Hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience

Journal Title: 
Haematologica
Primary Author: 
Griffin M
Author(s): 
Griffin M, Kulasekararaj A, Gandhi S, Munir T, Richards S, Arnold L, Benson-Quarm N, Copeland N, Duggins I, Riley K, Hillmen P, Marsh J, Hill A
Original Publication Date: 
Thursday, March 15, 2018

Free Full Text

http://www.haematologica.org/content/early/2018/03/09/haematol.2017.1830...

Bone Marrow Disease(s): 
  • aplastic anemia
  • paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.